Recent Headlines
Within Chemical Manufacturing
Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase
The Gotham Biotech Histoplasma Urinary Antigen EIA is an enzyme immunoassay (EIA) intended to qualitatively detect the presence of Histoplasma capsulatum galactomannan antigen in human urine specimens. This kit, when used in conjunction with other diagnostic measures, can be used as an aid in the diagnosis of histoplasmosis. - September 08, 2023 - Gotham Biotech
Industrial Data Labs Raises $1.5 Million in Seed Round to Drive Innovation in Industrial Sales Processes with Applied AI
Industrial Data Labs, a Houston, TX-based startup specializing in Applied AI technology for the Pipe, Valve, Fitting, and Flange (PVF) industry, is pleased to announce the successful closing of its Seed Round, securing $1.5 million in funding. This significant investment propels the company's... - August 30, 2023 - Industrial Data Labs
Gainful Solutions Welcomes Dr. Isaiah “Ike” Wilson III as a Partner
Gainful Solutions, an international consulting and lobbying firm, is honored to welcome Dr. Isaiah “Ike” Wilson III as a Partner. He has earned a reputation as a versatile and innovative soldier-scholar, and joins a strong team, some of whom he has worked with previously. - August 29, 2023 - Gainful Solutions
Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington’s Disease
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease (HD), today shares that the Phase 3 pivotal KINECT®-HD study conducted by HSG in collaboration with Neurocrine Biosciences,... - August 18, 2023 - Huntington Study Group
Huntington Study Group Announces Positive Topline Results for Virtual Unified Huntington’s Disease Rating Scale® (vUHDRS®) Study
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces positive topline results from its Virtual Unified Huntington’s Disease Rating Scale®... - August 14, 2023 - Huntington Study Group
Socomore Acquires Majority Stake of Flamemaster
The Flamemaster Corporation announced that on July 18, 2023, Socomore, with whom Flamemaster has various agreements including a joint development agreement, has increased its stake in the company from approximately 22.5% to approximately 73.97%. Socomore acquired about 52% of the outstanding shares... - August 12, 2023 - Flamemaster Corporation
Minus K Technology Announces Announces Its Eighth U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
Minus K Technology, over the past 30 years has worked with businesses, universities and laboratories all over the world, supplying negative-stiffness vibration isolation products for research within universities, aerospace, audio reproduction, crystal growth, neuroscience, biology, chemistry,... - August 09, 2023 - Minus K Technology Inc.
Leading Glass Fluid Filtration Company, Trucent, Appoints Michael Ondrus as Global Key Account Manager
Trucent Industrial Solutions proudly announces Michael Ondrus as the new Global Key Account Manager – Brittle Materials. Ondrus will lead Trucent's expansion in the global brittle materials fabrication market. Trucent Industrial Solutions, known for its Centrasep brand, is a renowned provider of fluid separation solutions for the glass and brittle materials sector. Ondrus will be based in Trucent's Industrial Solutions division in Noblesville, IN. - August 03, 2023 - Trucent
VitaliNatura Essentials™ Launches Exclusive Product Line for Women in Mid-Life and Beyond
VitaliNatura Essentials™, a 100% women-owned company, proudly launches an exclusive product line for women in mid-life and beyond. The collection includes premium vitamins and supplements tailored to cater to the unique needs of women in their mid-40s and after. The company's commitment to quality and empowerment shines through as they offer Adrenal Support Supplements, Magnesium Gummies, Sea Moss Gummies, Liver Support Capsules, Berberine Complex, Joint Health Capsules, and more. - August 01, 2023 - VitaliNatura Essentials DBA EngagePro Digital, LLC
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD
HSG Clinical Research, Inc. - the Huntington Study Group’s clinical research organization (CRO) and wholly owned subsidiary (collectively referred to here as HSG) - has begun providing CRO services for CHDI Foundation’s Enroll-HD observational study and clinical research platform in the... - July 25, 2023 - Huntington Study Group
Research Shows Specialty Chemicals and Materials Industry Experienced Significant Challenges in Q1
The specialty chemicals and materials industry experienced significant challenges in the first quarter of 2023 due to the ongoing macroeconomic slowdown, with a decline of 11% and 20% in volume and EBITDA, respectively, compared to the prior year. - July 24, 2023 - Creov Group
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US and Canada-based researchers. - July 13, 2023 - Cayman Chemical Company
Paras Biopharma (Biologics CDMO) Announces Industry Leading Scale-up Development & Production Process of an “Onco-Immunology Fc-fusion Biologic”
Paras Biopharma (Biologics CDMO) Finland team is pleased to announce that its extensive efforts have resulted in the successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” biologic. - July 12, 2023 - Paras Biopharmaceuticals Finland Oy
Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression in Microbial Systems – To Facilitate Economical Scale-Up in Production of Biologics
Paras Biopharma (Biologics CDMO) Finland, a leading biopharmaceutical technology development company in the Nordic region, maximises recombinant protein expression in Microbial Systems in its fully-equipped biologics production facility in Finland. - July 04, 2023 - Paras Biopharmaceuticals Finland Oy
Tialma's Aleksey Krylov Attending NewYorkBIO Life Science Company Showcase
Tialma, a CFO consultancy to the life science companies, is sharing that its lead consultant Aleksey Krylov will attend the highly anticipated NewYorkBIO Life Science Company Showcase, scheduled to take place on June 27, 2023. The NewYorkBIO Life Science Company Showcase is an esteemed event that... - June 27, 2023 - Tialma
Hugg & Hall Equipment Named Among Best Places to Work in Arkansas
Dealership named to Top 50 Best Places to Work in Arkansas by Arkansas Business Magazine Hugg & Hall Equipment Company, a leading industrial and construction equipment provider in Arkansas, Oklahoma, Louisiana, Missouri and Texas was recently named as one of the Best Places to Work in Arkansas... - June 26, 2023 - Hugg & Hall Equipment
Aleksey Krylov Joining Oncology Advanced Practice Forum Online Conference
Tialma, a CFO consultancy to the life science companies, is sharing that its lead consultant Aleksey Krylov will join Oncology Advanced Practice Forum Online Conference, scheduled to take place on June 26, 2023. Tialma chose this event because of its versatility, which enables networking... - June 26, 2023 - Tialma
Alventa Pharma Pvt. Ltd. Introduces Affordable Generic Pharmaceutical Drugs and Extends Contract Manufacturing Services
India-based Alventa Pharma, a leading third party manufacturing pharma, is excited to announce the launch of their cost-effective generic drugs in both domestic and international markets. Alongside being Third party manufacturing pharma, Alventa Pharma now expands its services as a contract... - June 21, 2023 - Alventa Pharma Limited
PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars
ALPCO Receives FDA 510(k) Clearance for the Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay. The Calprotectin Immunoturbidimetric (IT) Assay is now IVDD and 510(k)-cleared for in... - June 15, 2023 - ALPCO
Quadrant, Synonymous with Quality and Customer Service, Returns to Spray Foam Industry: Highly Experienced Team, Same Great Products
Quadrant Performance Materials (QPM) today launched as the latest spray foam manufacturing company to serve the construction industry. - June 14, 2023 - Quadrant Performance Materials
Keene Family Holdings Announces Rebranding as KEENE, Inc.
Keene Family Holdings, a prominent manufacturing company specializing building products and systems, is thrilled to announce its rebranding as KEENE, Inc. This strategic move comes after years of successful growth in building brands in both commercial and residential construction. The overall size... - June 07, 2023 - Keene Inc.
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
GenInvo Part of PHUSE US Connect & Informa Connect Clinical Data Disclosure, Transparency & Plain Language Summaries Event - 2023
GENINVO was a part of 2 recent global events for the life science industry. The first was "PHUSE US Connect 2023" which was held in Renaissance Orlando at SeaWorld Florida on 5th – 8th March 2023 and the second event, Informa Connect Clinical Data Disclosure, Transparency &... - June 05, 2023 - GenInvo, Inc.
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
Hood Guyz Expands Commercial Pressure Cleaning Services, Ensuring Sparkling Clean Surfaces for Businesses
Hood Guyz, a leading provider of commercial cleaning services, announces the expansion of their pressure cleaning services. With a focus on delivering exceptional results, their professional team ensures businesses have spotless and well-maintained surfaces. The expansion of their services allows them to cater to a wider range of industries and meet the growing demand for high-quality pressure cleaning solutions. - June 02, 2023 - Hood Guyz
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
OPTI•MIST® Introduces Innovative Organic Personal Care Products
OPTI•MIST® Organic Introduces Innovative Organic Personal Care Products Infused with a Powerful Mineral-Based Antiseptic for Enhanced Hygiene. OPTI•MIST, a pioneering brand in the personal care industry, is pleased to announce the launch of its revolutionary line of organic personal... - May 26, 2023 - OPTI-LAB INC.
AcceleDev Celebrates Its 20 Year Anniversary
AcceleDev Chemical LLC, a leading strategic supplier of Pharmaceutical process custom synthesis services, is proud to celebrate its 20th Anniversary this month. Since its inception in 2003, AcceleDev has remained focused on helping pharmaceutical and biotech companies deliver life-saving... - May 25, 2023 - AcceleDev Chemical LLC
Alpyne Strategy to Host Refrigerant Briefing for Spring 2023
Alpyne Strategy, a leading industrial and HVAC marketing agency in Murfreesboro, TN, will host a Refrigerant Briefing for Spring 2023 live webinar event on Thursday, June 8 at 12:00pm CST. In this 1-hour session, HVAC-R stakeholders can learn the top refrigerant insights from this spring. Topics... - May 21, 2023 - Alpyne Strategy
The Inc. Magazine, USA Includes Paras Biopharma (Biologics CDMO) as One of the Top 10 Most Innovative Biotech Companies to Follow in 2023
Paras Biopharma (Biologics CDMO), a biopharmaceutical technology development company is pleased to be included by The Inc. Magazine, USA as “One of the Top 10 Most Innovative Biotech Companies to Follow in 2023.” The Inc. Magazine serves as an online "go-to" informative tool for business leaders and entrepreneurs, including CEOs and owners of small-to-midsize companies to success, providing news, advice, and inspirational articles. - May 19, 2023 - Paras Biopharmaceuticals Finland Oy
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
Aculon® Signs Global Distribution Agreement with Ellsworth Adhesives
Aculon, Inc. signs non-exclusive global distribution agreement with Ellsworth Adhesives. The agreement allows Ellsworth Adhesives to distribute Aculon's NanoProof 3 Series, a drop-in replacement series to 3M's Novec electronic grade coatings. - May 18, 2023 - Aculon Inc
Gainful Solutions Welcomes Stephen Hayes as a Partner
Gainful Solutions, an international consulting and lobbying firm, and its Managing Partners, former Ambassador Michael Ranneberger and Mr. Soheil Nazari-Kangarlou, are honored to welcome Mr. Stephen Hayes as a partner. He is a distinguished creative innovator and leader in international organizational and program development. - May 17, 2023 - Gainful Solutions
ImaGEN Teams Up with Noah Chemicals to Introduce Cutting-Edge Chemical Solutions for Hydrogen Generation on Demand
ImaGEN Inc., a leader in hydrogen generation systems, has partnered with Noah Chemicals, a renowned chemical manufacturing and services provider, to develop a groundbreaking on-demand hydrogen generation technology that promises to revolutionize the energy industry. With potential applications... - May 17, 2023 - Noah Chemicals
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
Procolored's DTF Printer: A Sustainable Approach to Textile Printing
Procolored, a leader in digital textile printing, advances sustainable and healthy practices with its 8.2" Single Head A4 DTF Printer. The printer uses eco-friendly, human-safe inks and powders free of hazardous air pollutants and low in volatile organic compounds. Unlike traditional methods, DTF printing optimizes water and ink usage, reducing waste. The printer's high-quality, vibrant prints and safety measures make it a top choice for businesses aiming to reduce their environmental footprint. - May 13, 2023 - Procolored
BOC Sciences Reports Strong Capabilities of CDMO Operations
BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform. - May 10, 2023 - BOC Sciences
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate
BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production. - May 09, 2023 - BOC Sciences
RTS Consulting - Automation: New Focus on Manufacturing Shopfloor Business Solutions
RTS Consulting Automation, with over 30 years of experience helping North American manufacturing companies improve shopfloor performance, has now placed a laser focus on delivering shopfloor Industry 4.0/Digital Transformation solutions within their “MES and Controls Engineering” practices. RTS has also updated their logo to reflect the new focus, Digital Manufacturing. - May 08, 2023 - RTS Consulting - Automation
New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company
Liberum Independent Medical Education Announces Management Buyout
Liberum Independent Medical Education, provider of independent medical education (IME) to healthcare professionals worldwide, has announced a management buyout (MBO) from its original owner, OHC London Holdings Ltd. The MBO was led by the company's Managing Director, Celeste Kolanko who has taken ownership of the company which now operates as Liberum IME BV, and Liberum Independent Medical Education Ltd. - April 29, 2023 - Liberum Independent Medical Education Ltd
How to Select the Right Load Movement System - Podcast Now Available
AeroGo, manufacturer of innovative load moving equipment, launched a new seven-episode podcast, called, "Select the Right Load Movement System." Each episode covers a specific question used to narrow down the choices available to the listener’s situation. - April 26, 2023 - AeroGo, Inc.
Johari Digital Makes a Significant Contribution from Their CSR Fund to Support Innovation, Research & Incubation at IIT, Jodhpur
As a part of the Industry and Academia collaboration, Johari Digital Healthcare Ltd. donated a significant funding amount to IIT, Jodhpur Incubation & Innovation center from their CSR Fund to boost & strengthen Med-Tech Startup Ecosystem. Mr. Satyendra Johari, Executive Chairman &... - April 24, 2023 - Johari Digital Healthcare Ltd.
BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. - April 20, 2023 - BOC Sciences
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
DistillerSR Appoints New Board Members to Accelerate Scaleup and Healthcare Analytics Domain Expertise
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today welcomed Dr. Khaled El Emam and Jason Flick as new board members. The two serial entrepreneurs join Andrew Pinkerton, Partner at Thomvest Ventures, Maria Pacella,... - April 11, 2023 - DistillerSR